PMC5509495_01
Growth profiles of Probands. (A) Growth chart of Proband 1 (P1), arrow indicates start of GH treatment. (B) Growth chart of Proband 2 (P2). (C) Growth chart from Proband 3 (P3) during GH treatment.
nihms855031f1.jpg
PMC5509495_04_nihms855031f1.jpg
F1
During this period, rhGH therapy was started at a dose of 0.30 mg/kg/week (Figure 1C).
PMC5509495_02
PMC5509495_03
Growth profiles of Probands. (A) Growth chart of Proband 1 (P1), arrow indicates start of GH treatment. (B) Growth chart of Proband 2 (P2). (C) Growth chart from Proband 3 (P3) during GH treatment.
nihms855031f1.jpg
PMC5509495_04_nihms855031f1.jpg
F1
During this period, rhGH therapy was started at a dose of 0.30 mg/kg/week (Figure 1C).
PMC5509495_04
Growth profiles of Probands. (A) Growth chart of Proband 1 (P1), arrow indicates start of GH treatment. (B) Growth chart of Proband 2 (P2). (C) Growth chart from Proband 3 (P3) during GH treatment.
nihms855031f1.jpg
PMC5509495_04_nihms855031f1.jpg
F1
During this period, rhGH therapy was started at a dose of 0.30 mg/kg/week (Figure 1C).